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Abstract
Identification of organocatalysts functioning in aqueousBackground: 
environments will provide methods for more sustainable chemical
transformations and allow tandem reactions with biocatalysts, like enzymes.
Here we examine three water-soluble carbapenem antibiotics (meropenem,
doripenem, and ertapenem) as secondary amine organocatalysts in aqueous
environments.
The Michael addition of nitromethane to cinnamaldehyde was usedMethods: 
as the model reaction. The reactions were monitored by  H NMR, and the
enantioselectivity was determined by chiral HPLC.  
 The effects of buffer components, pH, organic co-solvents andResults:
anchoring into a protein scaffold were investigated. Moderate yields of the
Michael addition were obtained in buffer alone. The use of methanol as a
co-solvent in a ratio of 1:1 increases the yield by 50%. Anchoring of the
catalysts into a protein backbone reverses the enatioselectivity of the reaction.
 Despite only moderate yields and enantioselectivities beingConclusions:
obtained, this study lays the foundations for future development of efficient
organocatalysis in aqueous environments.
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Introduction
The need for more sustainable catalysts in chemical trans-
formations continues to attract significant interest1. Iminium 
ion catalysis facilitated by secondary amines retrieved con-
siderable attention in the early 2000’s due to their ability to 
activate enals for enantioselective nucleophilic addition2. Now 
known as organocatalysts, these small molecules are reasonably 
cheap, non-toxic, sustainable, and stable (i.e. tolerant to 
moisture and air)3. However, attempts to use organocatalysts in 
solvents like water as a homogenous system are yet to achieve 
great success4. This is because most organocatalysts have 
bulky hydrophobic groups that are important for creating chiral 
environments, but significantly lower their water solubility5. Not 
surprisingly, one of the most well-known water soluble organo-
catalysts is l-proline (1, Figure 1A) that bears no bulky hydro-
phobic group. However, at neutral pH in water the proximity of 
the carboxylate to the amine of l-proline, making the amine 
more prone to be protonated and consequently inhibiting forma-
tion of the substrate iminium ion and leading to poor catalytic 
activity6. In addition, the small chiral substituent in proline often 
hampers the enantioselectivity of the reactions.
Besides proline, several carbapenems (e.g. meropenem 2a, 
doripenem 2b, and ertapenem 2c; Figure 1) also have a sec-
ondary amine in the form of pyrrolidine. Carbapenems are β-
lactam antibiotics that inhibit enzymes in bacterial cell wall 
biosynthesis7. Just like proline, carbapenems are completely 
water soluble. However, the lack of an adjacent carboxylate 
group in carbapenems implies that these molecules should be 
able to form an iminium ion readily in aqueous environments for 
efficient catalysis. On the other hand, substituents around the 
pyrrolidine ring of carbapenems are larger than that of proline 
and likely to induce enantioselectivity for the catalysis8. In addi-
tion, an enhanced chiral environment can be created by anchoring 
carbapenems into a protein environment. For example, a covalent 
adduct 3 (Figure 2) is formed during the metabolism of carbap-
enems by penicillin binding proteins, and this intermediate can be 
trapped by mutating the key glutamic acid residue to an alanine 
residue to prevent the hydrolysis of the ester intermediate9.
Here we explored the uses of three carbapenem antibiotics, 
meropenem 2a, doripenem 2b and ertapenem 2c, as organocata-
lysts in aqueous systems. The effects of buffer components, pH, 
and organic co-solvents on reaction yield were investigated. 
We also tested whether anchoring a carbapenem in a protein 
scaffold increases the enantioselectivity of the reaction.
Methods
General procedure for the Michael addition of nitromethane 
to cinnamaldehyde
For the buffer screen, a concentration of 10 mM at pH 7.0 
was used for each of the following: (4-(2-hydroxyethyl)-1- 
piperazineethanesulfonic acid (HEPES), potassium phosphate 
(KPi), sodium phosphate (NaPi), or phosphate-buffered saline 
(PBS, i.e. sodium phosphate and sodium chloride). For dorip-
enem reactions, to a solution of doripenem (Glentham Life Sci-
ences #GA9212) (1.00 mg, 2.60 µmol, 1 eq) in the indicated buffer 
(495 µl) was added cinnamaldehyde (1.57 mg, 11.9 µmol, 5 eq) 
in MeOH (5 µl) and nitromethane (1.27 µl, 23.8 µmol, 10 eq). 
For meropenem reactions, to a solution of meropenem trihy-
drate (Ark Pharm Inc, #AK161987) (1.14 mg, 2.38 µmol, 1 
eq) in the indicated buffer (495 µl) was added cinnamaldehyde 
(1.72 mg, 13.0 µmol, 5 eq) in MeOH (5 µl) and nitromethane 
(1.39 µl, 26.0 µmol, 10 eq). For ertapenem reactions, to a solution 
of ertapenem sodium salt (Glentham Life Sciences, #GA8176) 
(1.04 mg, 2.10 µmol, 1 eq) in the indicated buffer (495 µl) 
was added cinnamaldehyde (1.39 mg, 10.5 µmol, 5 eq) in MeOH 
(5 µl) and nitromethane (1.12 µl, 21.0 µmol, 10 eq). The reac-
tions were then placed in a thermoshaker at 25°C and shaken at 
800 rpm for 24 hours.
For reactions carried out at pH 7.5 and pH 8.0, the buffers 
were adjusted with 1 M NaOH, and the pH measured using 
a pH meter. For the co-solvent screen the reactions were per-
formed by first adding 245 µl of the indicated buffer followed by 
250 µl of the indicated solvent.
For reactions in buffer alone, the reaction mixtures were extracted 
with 700 µl of CDCl3 and analyzed by 1H NMR spectroscopy. 
For those reactions with methanol or acetonitrile as the 
co-solvent, the solvents were evaporated under reduced pressure, 
and the crude mixture was extracted with 700 µl of CDCl3. 
Reactions containing benzene or chloroform as the co-solvent 
were performed using the corresponding deuterated solvents and 
subjected directly to NMR analysis. Product yields were esti-
mated from integration of signals arising from cinnamaldehyde 
Figure 1. Structures of carbapenems. (A) Structure of l-proline 1. (B) General structure of carbapenems 2. (C) Structure of meropenem 2a, 
doripenem 2b and ertapenem 2c. Pyrrolidine moieties that contain a secondary amine are colored in blue.
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6, product 7, and side product 8. 1H NMR spectra were recorded 
in CDCl3 or C6D6 on a Bruker Ascend 500 MHz or a Bruker 
Fourier 300 MHz instrument. Chemical shifts are reported in 
parts per million (ppm) and are referenced to the residual 
solvent resonance as the internal standard (CHCl3: δ = 7.26 ppm 
and C6H6: δ = 7.15 ppm). Spectra were analysed using 
Bruker TopSpin version 3.511.
The following conditions were used to carry out the modified 
(diluted) BlaC-carbapenem reactions. To a microcentrifuge tube 
was added 250 µl of the enzyme solution (10 mg, 324 nmol, 
0.2 eq) and to this was added 245 µl of reaction buffer (50 mM 
NaPi, 100 mM NaCl, pH 7.0). To the enzyme was added 5 µl 
of a stock solution of cinnamaldehyde in methanol, (213 µg, 
1.6 µmol, 1 eq) followed by 0.17 µl (195.2 µg, 3.2 µmol, 
2 eq) of neat nitromethane. The reactions were shaken at 
50 rpm, 25°C for 24 h. 700 µl of CDCl3 was added to the 
reactions when finished and the samples spun down in a micro 
centrifuge. The organic fraction was removed and subjected 
to 1H NMR analysis. The control reactions carried out in 
tandem with meropenem 2a and doripenem 2b were performed 
as follows. For doripenem reactions, to a solution of doripenem 
(136 µg, 324 nmol, 1.0 eq) in PBS buffer (495 µl) was added 
cinnamaldehyde (213 µg, 1.6 µmol, 5 eq) in MeOH (5 µl) 
and nitromethane (3.2 µmol, 2 eq). For meropenem reactions, 
to a solution of meropenem trihydrate (124 µg, 324 nmol, 1 eq) 
in PBS buffer (495 µl) was added cinnamaldehyde (213 µg, 
1.6 µmol, 5 eq) in MeOH (5 µl) and nitromethane 0.17 µl 
(3.2 µmol, 2 eq).
Determination of enantioselectivity
The stereoselectivity of products 7 were determined by chiral 
high-performance liquid chromatography (HPLC) analysis. 
Enantioenriched samples of (S)- and (R)-nitro products for peak 
assignment in chiral HPLC measurements were obtained using 
l- and d-Jørgensen-Hayashi catalysts according to the literature 
procedure5. A racemic sample of the nitro product was obtained 
using piperidine as the catalyst12. The aldehyde was reduced 
to the alcohol for determining the ratio of two enantiomers 
(Scheme S1).
Scheme 1. Michael addition of nitromethane 5 to cinnamaldehyde 6 as the model reaction resulting in the 1,4-addition product 7 and 
sometimes the 1,2-addition side product 8.
Figure 2. Metabolism of carbapenems 2 by penicillin binding proteins. (A) Carbapenem metabolism. (B) Crystal structure of intact 
meropenem 2a in Mycobacterium tuberculosis β-lactamase BlaC, a penicillin binding protein, before metabolism; pdb: 3DWZ10.
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The reactions were scaled up 10 times with respect to the 
above screening conditions for the reactions with meropenem 
and doripenem in pH 7.0 PBS buffer and with 50% methanol 
and performed in 10-ml round bottom flasks with continuous 
stirring at room temperature for 24 h. The protein reactions 
were scaled up 10 times with respect to the reactions used for 
screening.
The reaction mixture was then extracted with DCM (10 ml × 3), 
and the organic fractions were combined, dried over anhy-
drous Na2SO4, filtered and concentrated under reduced pressure 
to ca. 1 ml before purification by preparative TLC (EtOAc:
hexane = 25:75). The silica gel was scraped from the plate and 
stirred in 1% MeOH:DCM (10 ml). The suspension was filtered 
and evaporated under reduced pressure.
The resulting aldehyde was dissolved in methanol (5 ml), and 
to this was added ca. 5 equivalents of NaBH4. The reaction was 
stirred overnight at room temperature. The reaction mixture was 
then neutralized with 1 M HCl(aq), and then extracted with DCM 
(10 ml x 3). The organic fractions were combined, dried over 
Na2SO4, filtered and concentrated under reduced pressure. The 
resulting alcohol was purified by preparative TLC (EtOAc:hex-
ane = 35:65). The silica was scraped from the plate and stirred 
in 1% MeOH:DCM (10 ml). The solution was filtered and 
evaporated under vacuum.
The purified alcohol was dissolved in 1 ml of 20% 2-propanol 
in hexane (HPLC grade). 20 µl of each sample was injected onto 
the HPLC.
The reactions catalyzed by meropenem 2a and doripenem 2b 
were scaled up ten times from the above conditions and the reac-
tion mixtures were extracted with dichloromethane, dried over 
Na2SO4, filtered, and concentrated. The product 7 was purified 
by preparative TLC (25% EtOAc in hexane). The product was 
dissolved in 5 ml of methanol, and approx. 5 equivalents of 
NaBH4 were added. After overnight stirring at room tempera-
ture, the reaction mixture was neutralized with 1 M HCl(aq), 
extracted with dichloromethane (3 × 10 ml), dried over Na2SO4, 
filtered, and concentrated. The resulting alcohol 9 was puri-
fied by preparative TLC (35% EtOAc in hexane) before analysis 
by chiral HPLC using a Phenomonex Cellulose-Lux1 analytical 
chiral column held at 20°C (isocratic elution 0.5 ml/min 
with 25% 2-propanol in n-hexane; detection by absorbance at 
210 nm).
To determine the enantioselectivity of the BlaC-carbapenem 
complexes, the reactions were scaled up 10 times with regards 
to the small-scale screening reactions. Enantioselectivity was 
then determined using the above method.
Cloning, expression and purification of BlaC(E166A)
The gene encoding for the wild-type Mycobacterium tuberculosis 
β-lactamase (BlaC) without the 40-amino acid leader sequence 
was purchased as a double-stranded fragment (GeneArt, 
Invitrogen; see Supporting Information for the exact DNA 
sequence). This was cloned into a NdeI and BamHI digested 
pET28a vector by Gibson assembly to yield the wild type 
gene with an N-terminal 6 his-tag originating from the vector. 
Briefly, 25 ng of the linear gene was added to 100 µg of 
digested plasmid and to this was added 0.5 µl of sterile H2O fol-
lowed by 2.5 µl of Gibson assembly master mix (NEB). The 
mixture was then incubated at 50°C for 1 hour. The products 
were transformed into chemically competent MDS42 E. coli 
cells and grown overnight. Colonies were selected and cultured 
overnight after which the plasmid was purified by the miniprep 
method (Qiagen). The construct was confirmed by DNA 
sequencing.
The E166A mutation was introduced by site-directed mutagenesis 
PCR using PrimeStar HS DNA polymerase (Clonetech) with 
primers CTGGATGCAGAAGCACCGGAACTGAATC (forward) 
and GATTCAGTTCCGGTGCTTCTGCATCCAG (reverse). 
PCR was performed over 33 cycles. The initial temperature was 
95°C and held for 3 minutes. Each cycle comprised of 10 seconds 
for denaturation at 98°C, followed by annealing for 5 seconds 
at 60°C and finally an extension of 6 minutes and 30 seconds at 
72°C. The final extension was 10 minutes. The mutant construct 
was confirmed by DNA sequencing (Eurofins, Genomics) using 
the T7 promoter primer (TAATACGACTCACTATAGG).
Plasmid pET28a BlaC(E166A) was then transformed into chemi-
cally competent BL21(DE3) cells and grown on LB agar plates 
supplemented with kanamycin (37.5 µg/ml). One colony from 
the plate was picked to inoculate a 10 ml LB starter culture 
containing kanamycin (37.5 µg/ml). After overnight, the starter 
culture was diluted into 1 L of fresh LB media containing 
kanamycin (37.5 µg/ml). The cells were grown at 37°C until 
they reached an OD600 of 0.8, and IPTG was added to reach a 
final concentration of 0.5 mM. The cells were then incubated 
overnight at 20°C. The cultures were harvested and the dry pellet 
was stored at –20°C.
To purify the enzyme, the cells were lysed by sonication in 
sodium phosphate buffer (35 ml per litre pellet, 50 mM NaPi, 
100 mM NaCl, 10 mM imidazole, pH 8.0) with either 5 mg 
meropenem or doripenem added to the re-suspended cells. The 
solids were separated by centrifugation at 20,000 rpm for 30 
minutes. The supernatant was loaded on to a Ni-NTA column 
equilibrated with the above buffer. The column was washed twice 
with wash buffer (25 ml, 50 mM NaPi, 100 mM NaCl, 25 mM 
imidazole, pH 8.0) and then the protein was eluted in phosphate 
buffer (10 ml, 50 mM NaPi, 100 mM NaCl, 300 mM imidazole, 
pH 8.0). 1 mg of doripenem or meropenem was added to 
the elution fraction and incubated for 30 minutes at room 
temperature. Fast protein liquid chromatography (FPLC) was 
performed on an ÄKTA purifier (GE Healthcare) system at room 
temperature using a ProteoSEC size exclusion column (Generon, 
SEC-3-70-100 ml, 26 mm ID, 60 cm length, 3–70 kDa HR resin). 
Protein elution was monitored by UV absorbance at 280 nm 
and the elution buffer was 50 mM sodium phosphate 
buffer 100 mM NaCl pH 7.0. Fractions containing BlaC- 
carbapenem complexes 3 were combined and concentrated using 
a 10 kDa cutoff centrifugal concentrator. Expression and purifica-
tion were confirmed by sodium dodecyl sulfate–polyacrylamide 
gel electrophoresis (SDS-PAGE) (Figure 3). SDS-PAGE was 
performed using self-casted 12% acrylamide gels and run for 
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50 minutes at 200 V. SDS-PAGE gels were stained using 
Coomassie Brilliant Blue. Unstained protein molecular weight 
marker (Thermo Scientific) was run alongside the samples.
Protein-carbapenem complexes were confirmed by Liquid 
chromatography mass spectrometry (LC-MS). LC-MS was per-
formed on a Waters Synapt G2-Si quadrupole time of flight 
mass spectrometer coupled to a Waters Acquity H-Class UPLC 
system. The column was an Acquity UPLC protein BEH C4 
(300 Å 1.7 µm × 2.1 mm × 100 mm) operated in reverse phase 
and held at 60°C. The gradient employed was 95% A to 35% A 
over 50 minutes, where A is H2O with 0.1% HCO2H and B is ace-
tonitrile (ACN) with 0.1% HCO2H. Data was collected in positive 
ionization mode and analysed using the Waters MassLynx 
software version 4.1. Deconvolution of protein charged states 
was obtained using the maximum entropy 1 processing software.
Results and discussion
Here we chose the Michael addition of nitromethane 5 to 
cinnamaldehyde 6 (Scheme 1) as the model reaction to test 
whether meropenem 2a, doripenem 2b, and ertapenem 2c 
can function as catalysts. We first investigated different buffer 
conditions (Table 1). In the presence of 20% catalyst, all four 
buffers produced similar yields with each catalyst, but sig-
nificantly higher yields were observed for meropenem 2a and 
doripenem 2b in comparison to ertapenem 2c. It is notewor-
thy that no product was formed in non-buffered conditions (i.e. 
pure water), suggesting the need for a controlled pH throughout 
the catalytic cycle13. On the other hand, the presence of NaCl in 
PBS buffer had minimal impact on product yield. Since PBS 
is a common buffer used to mimic biological environments, this 
buffer was chosen for further investigations.
Modification of pH
We then shifted our attention to modify the reaction pH (Table 2). 
PBS adjusted to the relevant pH was employed. Although the 
conversion of the starting material 6 seems to increase at the 
elevated pH, the yield of the product did not. We found that 
this was due to formation of the side product 8 by 1,2-addition 
of nitromethane to cinnamaldehyde 6. As side product forma-
tion was least prominent at pH 7.0, we determined that this is 
the preferred pH for the reaction.
Optimization of yield
To optimize the reaction yield, we decided to explore the effects 
of different organic solvents as a co-solvent (Table 3). Four 
solvents were chosen and tested in a 1:1 ratio to the PBS buffer 
Table 1. Percentage yields of 7 from the model 
reaction with different buffers at pH 7.0. Yields 
were estimated using 1H NMR.
Catalyst H2O HEPES KPi NaPi PBS
Meropenem 2a 0 33 38 33 35
Doripenem 2b 0 38 29 39 31
Ertapenem 2c 1 8 9 8 13
Table 2. Percentage yields of product 
7 and side product 8 in 10 mM PBS at 
indicated pH. Yields were estimated using 
1H NMR.
Catalyst pH 7.0 pH 7.5 pH 8.0
7 8 7 8 7 8
Meropenem 2a 35 1 25 75 23 25
Doripenem 2b 31 1 34 26 29 28
Ertapenem 2c 13 0 8 4 5 3
Figure 3. SDS-PAGE analysis for the expression and purification of BlaC. (A) Expression of BlaC: i, before induction; ii, after induction. 
(B) Nickel affinity chromatography of BlaC-meropenem complex 3a: i, flow through; ii, wash 1; iii, wash 2, iv, elution. (C) Elution of BlaC-
meropenem complex 3a from size exclusion chromatography.
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or if the concentration of the BlaC-carbapenem complex 
3 exceeded 500 µM in PBS. Thus, we were not able to test the 
conditions giving the highest yields (i.e. 1:1 = PBS: MeOH), 
and the reactions were carried out at diluted concentration in 
PBS (Table 5). Under the new conditions, we were able to 
maintain the ratio of BlaC-carbapenem complexes (20 mol% 
3) to cinnamaldehyde 6 and negligible precipitation of protein 
complexes was observed during the time course of the reaction. 
Under the new (diluted) condition, as expected, lower yields 
were obtained with either meropenem 2a or doripenem 2b 
compared to the previous conditions (Table 1, Table 5). While no 
product was obtained in the presence of BlaC only, some prod-
ucts were obtained in the presence of BlaC-meropenem 3a or 
BlaC-doripenem 3bcomplexes, although there was no signifi-
cant change in product yield compared to the carbapenems 2 
alone (Table 5). Notably, inversion of enantioselectivity was 
observed when the catalyst was anchored in the protein scaf-
fold, although the enantioselectivity is still low. Raw data for all 
experiments conducted in this study, including the supporting 
information, are available on figshare15.
Conclusions
Here we investigated the ability of carbapenem antibiotics 2a-c 
to catalyze the Michael addition of nitromethane to cinnamal-
dehyde 6 in aqueous environments. While ertapenem 2c is not 
effective, catalysis by meropenem 2a or doripenem 2b provides 
the product 7 with moderate yields and enantioselectivities.
The results suggest the carbapenems 2a-c can form iminium 
ions in situ, facilitating the nucleophilic addition of nitrometh-
ane for Michael addition in water. The charged iminium 
intermediate may be stabilized by polar protic solvents (e.g. 
water, methanol). This is consistent with the observation that 
higher yields were obtained when using methanol as a co-solvent. 
On the other hand, polar aprotic solvents (e.g. acetonitrile) 
had little effect. Addition of non-miscible solvents (e.g. 
benzene, chloroform) into the buffer system was not beneficial 
for catalysis, most likely due to the preferential partition of the 
starting materials into the organic phase, whereas the catalyst 
remains in the aqueous phase, hindering catalysis.
It does not seem that the substitution around the active nitrogen 
is enough to induce high enantioselectivity onto the product at 
25°C. Attack from either the re or si face of the iminium ion seems 
to be equally possible for meropenem 2a and doripenem 2b.
Table 4. Enantiomeric ratio (R:S) of 
the product 7. Ratio calculated from 
integration of chiral high-performance liquid 
chromatography peaks.
Catalyst PBS only 1:1 PBS:MeOH
Meropenem 2a 43:57 41:59
Doripenem 2b 43:57 47:53
Table 3. Percentage yields of 7 from the model reaction in the 
presence of different co-solvents. Yields were estimated using 
1H NMR.
Catalyst Miscible co-solvent Non-miscible co-
solvent
Methanol Acetonitrile Benzene Chloroform
Meropenem 2a 71 19 0 0
Doripenem 2b 74 27 1 2
Ertapenem 2c 22 5 0 6
(10 mM, pH 7.0). These solvents are either miscible (metha-
nol and acetonitrile) or non-miscible (benzene and chloroform) 
with the buffer. Addition of methanol was found to significantly 
increase the product yield, whereas acetonitrile had negligible 
effects, and the use of the non-miscible solvents totally abolished 
the product formation.
As reasonable yields could be obtained using either meropenem 
2a or doripenem 2b as the catalyst, chiral HPLC was employed 
to identify the enantioselectivity under these conditions. Reac-
tions were performed on a larger scale to facilitate product 
purification and isolation by preparative TLC. The aldehyde 
functionality in the product 7 was reduced by treatment with 
NaBH4 to afford the corresponding alcohol 9 before analysis 
by chiral HPLC (see Supporting Information)5. In general, no 
significant difference in the enantioselectivity was observed for 
either meropenem 2a or doripenem 2b (Table 4), and the addi-
tion of methanol also had little effect. In fact, enantiomeric 
excess is low in all cases, with the best result of R:S = 41:59 
observed with meropenem 3a in the mixture of PBS and 
methanol.
Improving enantioselectivity
To improve the enantioselectivity, we anchored meropenem 2a 
or doripenem 2b into the M. tuberculosis β-lactamase BlaC. 
This enzyme is known to metabolize carbapenems (Figure 2A). 
However, mutation of Glu166 to Ala can prevent hydrolysis 
of the ester intermediate 314, enabling stable anchoring of the 
antibiotics to BlaC. Recombinant BlaC(E166A) containing a 
N-terminal His-tag was produced in Escherichia coli BL21 
(DE3). Cells were lysed in the presence of meropenem 2a or 
doripenem 2b, and the protein complex was purified by nickel 
affinity and size exclusion chromatography (Figure 3). Formation 
of the protein complexes 3a and 3b with covalently bound 
ester intermediate were confirmed by mass spectrometry 
(Figure 4).
The Michael reaction was then performed with the BlaC- 
carbapenem complexes 3a and 3b. Attempts to perform 
reactions with BlaC-carbapenem 3a or 3b using the experi-
mental conditions in Table 4 were not successful as the enzyme 
complexes precipitated in buffers containing > 10% (v/v) methanol 
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The crystal structure of the BlaC-carbapenem complex 
(Figure 2) suggests that access to the amine by the substrates is 
still possible when meropenem 2a is bound to BlaC. Indeed, 
anchoring the carbapenems 2a and 2b into the protein produced 
similar yields to the catalysts alone. However, an inversion 
of stereoselectivity was observed for the BlaC-carbapenem 
complexes 3, suggesting that the protein environment surround-
ing the catalyst determines the enantioselectivity. The low enan-
tioselectivity may be due to the sub-optimal local environment 
provided by the wild-type protein, and engineering of this 
pocket by mutagenesis may increase both reaction yields 
and enantioselectivities, as demonstrated previously in artificial 
metalloenzymes16.
In this study, we have shown that water-soluble carbapenem 
antibiotics 2a-c can be repurposed to catalyze Michael addi-
tion. Unlike most organocatalysts used in aqueous systems17, 
these catalysts do not require emulsion or biphasic systems. 
Separation of the catalysts from the product can be achieved 
easily by extraction without the need for chromatography. 
Identification of organocatalysts functioning in aqueous environ-
ments will provide more sustainable approaches for chemical 
transformations and allow tandem reactions with biocata-
lysts, such as enzymes. However, there exists room to improve 
the system reported here, as only moderate yields and enanti-
oselectivities were obtained. Nonetheless, this study lays the 
foundations toward developing efficient iminium catalysis in 
Figure 4. Deconvoluted ESI-MS of purified BlaC enzymes. (A) BlaC reference mass = 30476 Da (30654 Da = BlaC + F-Met) (B) BlaC + 
meropenem = 30859 Da (31038 Da = BlaC + meropenem + F-Met, 30816 Da = retro aldol product of meropenem bound to BlaC) (C) BlaC 
+ doripenem = 30897 Da (31075 Da = BlaC + doripenem + F-Met, 30853 Da = retro aldol product of doripenem bound to BlaC) (D) Retro 
aldol product of the carbapenems.
Table 5. Percentage yields and 
enantiomeric ratio of 7 in the presence 
of BlaC-carbapenem complexes 3. 
Yields were estimated using 1H NMR. Ratio 
calculated from integration of chiral high-
performance liquid chromatography peaks.
Catalyst Yield (%) R: S
Meropenem 2a 22 43:57
BlaC-meropenem 3a 20 55:45
Doripenem 2b 23 46:54
BlaC-doripenem 3b 27 58:42
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water and provides new strategies of anchoring small molecule 
catalysts into chiral protein environments.
Data availability
The H NMR spectra, chiral HPLC chromatograms and full 
protein LC-MS chromatograms, and mass spectra datasets 
generated during and/or analyzed during the current study are 
available in the figshare repository: https://doi.org/10.6084/
m9.figshare.697388015.
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